Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach

Feuer, Gerold; Lakhi, Nisha; Barker, James H.; Salmieri, Stephen S.; Burrell, Matthew O.

doi:10.1016/j.ygyno.2013.09.022

Cited by 53 publications

(31 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the study by Feuer et al, 20 they reported a total average of 13.3 nodes for their ovarian cancer patients although they did not specify nodal type. The Gorostidi et al 19 investigation documented an average total nodal resection of 20 (6.5 PLNs and 13.5 PALNs) with their 2 early-stage ovarian cancer patients who underwent a robotic-assisted lymphadenectomy; Ditto et al 26 The intraoperative complication rate for the present study was quite low; we suspect that this was partially attributed to the use of the ENDOPOUCH retrieval system; the procedure uses 2 supportive arms that facilitate manipulation and specimen removal, thereby mitigating the risk for tissue spillage or seeding.…”

Section: Discussionmentioning

confidence: 99%

“…5,16,22Y25 Numerous early stage ovarian cancer studies have evaluated the utility of laparoscopic staging, 16,22,23,26 although there are scant data documenting the use of this procedure via robotic-assisted surgery (Table 3). 19,20 In the current investigation, we scrutinized the data from 26 early-stage ovarian cancer patients for whom roboticassisted disease staging was indicated. We encountered a reasonable operative time of 2.90 hours for the study group, which is comparable to the 2.32 hours reported by Feuer et al 20 that involved a comparison of robotic-assisted surgery (n = 63) and abdominal surgery (n = 26) in the management of ovarian cancer.…”

Section: Discussionmentioning

confidence: 99%

“…13,17,18 Despite the reported similarities between laparoscopic and robotic-assisted surgery, the data encompassing roboticassisted systematic lymphadenectomy in patients with earlystage ovarian cancer are quite limited. 19,20 Hence, the primary objectives of the current investigation were to evaluate the feasibility and perioperative outcomes associated with roboticassisted comprehensive staging in the management of earlystage ovarian cancer.…”

mentioning

confidence: 99%

See 2 more Smart Citations

The Safety and Feasibility of Robotic-Assisted Lymph Node Staging in Early-Stage Ovarian Cancer

Brown

Mendivil

Abaid

et al. 2014

Int J Gynecol Cancer

View full text Add to dashboard Cite

The results from this study suggest that robotic-assisted surgical staging in the management of presumed early-stage ovarian cancer is both feasible and associated with a minimal patient complication rate. We encountered a low incidence of lymph node metastases, and the readmission rate was favorable. Nevertheless, because the prevalence of lymph node metastases can approach 20% in select patients, physicians should consider a systematic lymph node resection to confer an optimal clinical assessment.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

The Safety and Feasibility of Robotic-Assisted Lymph Node Staging in Early-Stage Ovarian Cancer

Brown

Mendivil

Abaid

et al. 2014

Int J Gynecol Cancer

View full text Add to dashboard Cite

show abstract

“…Based on ontogenetic development, a new surgical concept has now been developed for compartment-based radical peritoneal mesometrial resection (PMMR) and therapeutic lymphadenectomy, according to Höckel, for the purpose of reducing locoregional recurrence. (38,39). The necessity to operate in all four quadrants implies re-docking and rotation of the operating table.…”

Section: Application In Malignant Gynecological Diseasementioning

confidence: 99%

“…Simultaneously, there appears to be no evidence of any drawbacks. Attempts have also been made to use the robot for de-bulking surgery in ovarian cancer (38,39). The necessity to operate in all four quadrants implies re-docking and rotation of the operating table.…”

Section: Application In Malignant Gynecological Diseasementioning

confidence: 99%

Robotic surgery in gynecology

Alkatout

Mettler

Maass

et al. 2016

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

Review 224 Robotic surgery in gynecologyRobotic surgery is a dynamic development for minimally invasive procedures. The specialty of gynecology consistently offers new opportunities for innovative surgical techniques and the advancement of existing therapy approaches (Figure 1). Ever since the American FDA granted approval of the Da Vinci operation robot for gynecological operations in 2005, about three million robotic operations have been performed worldwide. 3500 Da Vinci systems are currently in use: 586 of these in Europe and 77 in Germany (4 th quarter of 2015). According to the figures of Intuitive Surgical, about 600,000 interventions were performed on a worldwide basis in the year 2014, of which 50% were performed in gynecology, approximately 30% in urology, and about 20% in general and chest surgeries. In 2011, the proportion of robotic hysterectomies performed for benign indications in the USA was as high as 27% (1). Currently, we have experience in robotic surgery for the majority of gynecological operations and fields of application. The known advantages of minimally invasive surgery, such as less blood loss, shorter durations of hospital stay, and lower patient morbidity compared to open procedures, have been observed here as well. Better exposure of the operating field by 3D technology and the extension of surgical instruments to 7 degrees of freedom permit the use of minimally invasive surgery, even for complex indications. Robot-assisted manipulation of the instruments permits tremor-free handling and reduces work fatigue for the surgeon, which is very advantageous for the surgeon as well as the patient in long and complex interventions. The possibility of working simultaneously on two parallel consoles shortens the learning curve, reduces complication rates, and facilitates the training of surgeons (2). The advancement of robotic surgery in terms of the Da Vinci Xi permits the variable use of optics in all four trocars (paraaortic lymphadenectomy, omentectomy, or interdisciplinary surgery in the upper abdomen can be performed without re-docking) and ensures markedly greater flexibility due to the optimized geometry of the so-called patient cart. Robotic surgery has been criticized for the fact that it requires the use of larger trocars compared to conventional laparoscopy, and is therefore associated with more numerous and larger cosmetic scars; this is avoided by the smaller trocars now used in robotic surgery (3). The development of the single-site systems signifies further new options for the gynecological surgeon (Figure 2). For instance, freedom of movement is now maximized by the introduction of one or more additional working trocars (4, 5). The low level of postoperative pain appears to be another advantage. It is accompanied by a lesser need for analgesics and even shorter hospital stays compared to traditional laparoscopic surgery. One explanation could be the fact that the abdominal wall need not be used as a counter bearing. The absence of irritation and the advantage of tissue protec...

show abstract

Minimally invasive surgery (robotic or laparoscopic) versus laparotomy for advanced ovarian cancer

Uwins

Michael

Skene

et al. 2021

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach

Cited by 53 publications

References 15 publications

The Safety and Feasibility of Robotic-Assisted Lymph Node Staging in Early-Stage Ovarian Cancer

The Safety and Feasibility of Robotic-Assisted Lymph Node Staging in Early-Stage Ovarian Cancer

Robotic surgery in gynecology

Minimally invasive surgery (robotic or laparoscopic) versus laparotomy for advanced ovarian cancer

Contact Info

Product

Resources

About